Rate-Regulating Cardiac Therapy System Using Temperature Sensors
Through a rate response system based on blood temperature, the misunderstanding and response lag problems of cardiac pacemakers when adjusting pacing rate are solved, and accurate response to activity levels and stability of pacing rate are achieved.
Patent Information
- Application Number
- CN202080023170.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-03-22
- Filing Date
- 2020-03-19
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2040-03-19
AI Technical Summary
Existing cardiac pacemakers have misunderstandings and response lag issues when adjusting pacing rates, especially relying on accelerometers and blood temperature sensors, which cannot accurately respond to different levels of activity, resulting in inappropriate pacing rate control.
A rate response system based on blood temperature is adopted to properly adjust the pacing rate by measuring the core body temperature signal, generating relative temperature signals, moving the baseline temperature signal and proportional response signals to ensure that the pacing rate matches the activity level.
Accurate response to exercise and rest states is achieved, adaptability and stability of pacing rates is improved, inappropriate rate control is reduced, and the accuracy of heart rhythm management is improved.
Smart Images

Figure CN113631220B_ABST
Abstract
Description
[0001] Priority claim
[0002] This application claims priority to U.S. Provisional Patent Application No. 62 / 822,295, filed on March 22, 2019, entitled “SYSTEM AND METHOD FOR RATEMODULATED CARDIAC THERAPY UTILIZING A TEMPERATURE SENOR.”
[0003] Related patents
[0004] This application is related to commonly assigned U.S. Patent Nos. 9,833,624 and 10,159,841, both entitled "SYSTEM AND METHOD FOR RATE MODULATED CARDIAC THERAPY UTILIZING ATEMPERATURE SENOR." Technical Field
[0005] The present disclosure relates to medical devices and methods for cardiac rhythm management. More specifically, embodiments disclosed herein relate to systems and methods for automatically adjusting operating parameters of a cardiac rhythm management system. Background Art
[0006] The normal human heart supplies oxygen and removes waste by providing a demand-based blood supply to all tissues of the body. The amount of blood pumped through the body is determined by the person's heart rate and stroke volume. The heartbeat of a normal healthy resting individual is about 60 beats per minute (beats per minute, bpm), and the heartbeat is regulated by a complex autonomic control mechanism that manages the rate at which the sinoatrial (SA) node fires. The SA node controls the heart rate. When an individual is working, there is an increased metabolic demand for tissues, and the autonomic control system responds by causing the SA node to fire faster, thereby increasing the heart rate. In healthy individuals, the interaction of the nervous system, the SA node, and heart rate ensures that balance is maintained at all levels of activity.
[0007] Most modern pacemakers have the ability to approach the changing needs of the body based on activity by using an electrical component called an accelerometer. For example, many pacemakers include an accelerometer that can detect motion (and more specifically, acceleration), which acts as a proxy for activity. When a person walks, runs, or does other activities, the change in motion sends a signal to the internal electronics of the pacemaker, causing the pacemaker to increase the heart rate in order to provide increased blood supply to the active person. The limitation of relying on an accelerometer to adjust the pacing rate is that the accelerometer can interpret any movement as the patient's activity, such as riding in a car or riding a bicycle on a bumpy road, which may cause the pacemaker to inappropriately increase the pacing rate. In other words, the accelerometer will mistakenly interpret the increase in certain movements as an increase in patient activity, even if the increase in such movement is not actually due to an increase in patient activity. Another limitation of relying on an accelerometer to adjust the pacing rate is that in some cases, the accelerometer may not detect an increase in patient activity that is not accompanied by device vibration, such as when an individual rides a stationary bicycle while keeping his upper body relatively still. Both of these situations can cause the pacemaker to misinterpret activity and deliver inappropriate pacing rate control.
[0008] Another method of controlling the pacemaker rate is through the use of a blood temperature sensor. A rise in a person's core body temperature (usually preceded by a small drop in core body temperature) is often observed at the onset of activity and can serve as an alternative to an accelerometer. However, current pacemakers that rely on a person's core body temperature to adjust the pacing rate sometimes fail to respond appropriately and / or adequately to changes in a person's activity level. Summary of the invention
[0009] The following is a summary of several sample aspects of the present disclosure. It should be understood that this summary is provided for the convenience of the reader and does not completely limit the scope of the present disclosure. For convenience, one or more aspects or embodiments of the present disclosure may be simply referred to herein as "some aspects" or "certain embodiments".
[0010] Generally speaking, the present disclosure relates to cardiac rhythm management systems and methods of use thereof that provide an appropriate and proportional increase in pacing rate in response to exercise based on a measurement of blood temperature.
[0011] Certain embodiments of the present technology are related to an implantable medical system and a method of using the same that provides a temperature-based rate response for a patient in which the implantable medical system is implanted. Such an implantable medical system may include a single implantable medical device (IMD), or multiple IMDs that can communicate with each other. This method may include sensing a blood temperature signal indicating the core body temperature of a patient in which the IMD is implanted, and generating a relative temperature signal based on the blood temperature signal. According to certain embodiments, the relative temperature signal may be generated by generating a short-term average (STA) of the blood temperature signal, generating a long-term average (LTA) of the blood temperature signal, and subtracting the LTA of the blood temperature signal from the STA of the blood temperature signal to generate the relative temperature signal. The method may further include generating a moving baseline temperature signal based on the relative temperature signal, generating a proportional response signal based on the relative temperature signal and the moving baseline temperature signal, and generating a sensor-indicated rate response signal based on the proportional response signal and the basic rate. In addition, the method may include controlling the pacing rate of the implantable medical system based on the sensor-indicated rate response signal.
[0012] According to certain embodiments, the moving baseline temperature signal is generated based on the relative temperature signal in the following manner: the moving baseline temperature signal is generated so that it follows the relative temperature signal during the initial drop of the blood temperature signal occurring during the initiation of activity, and decays toward zero during the rise of the blood temperature signal after the initial drop of the blood temperature signal. For example, the proportional response signal can be generated by subtracting the moving baseline temperature signal from the relative temperature signal to generate a difference signal indicating the difference between the relative temperature signal and the moving baseline temperature signal, and the proportional response signal can be generated based on the positive part of the difference signal. For example, the positive part of the difference signal can be multiplied by a proportional gain value to generate the proportional response signal. Alternatively, a predetermined function can be applied to the positive part of the difference signal to generate the proportional response signal. During the rise of the blood temperature signal after the initial drop of the blood temperature signal occurring during the initiation of activity, the proportional response signal can provide an increase in the pacing rate based on the difference between the relative temperature signal and the moving baseline temperature signal. In addition, during the drop of the blood temperature signal occurring in response to a reduction or cessation of activity, the proportional response can provide a decrease in the pacing rate based on the difference between the relative temperature signal and the moving baseline temperature signal.
[0013] According to certain embodiments, a drop response signal and / or a slope response signal may also be generated and used to generate a sensor indicated rate response signal. During an initial drop in the blood temperature signal that occurs during the start of activity, the drop response signal may provide an increase in the pacing rate. During a rise in the blood temperature signal after the initial drop in the blood temperature signal, the slope response signal may provide an increase in the pacing rate based on the slope of the relative temperature signal. In certain embodiments, the sensor indicated rate response signal is generated based on a combination of a proportional response signal, a drop response signal, a slope response signal, and a basic rate. For example, the sensor indicated rate response signal may be generated by summing the proportional response signal, the drop response signal, the slope response signal, and the basic rate. According to certain embodiments, the amplitude and / or slew rate of the sensor indicated rate response signal is limited to prevent the pacing rate from exceeding a maximum rate and / or to prevent changes in the pacing rate from exceeding a maximum rate of change.
[0014] According to certain embodiments, a falling response signal may be generated by comparing the relative temperature signal with a falling threshold, providing a falling start rate value to an input of an integrator when the relative temperature signal is less than the falling threshold, providing a falling decay rate value to an input of an integrator when the relative temperature signal is greater than the falling threshold, and using a positive portion of the signal output by the integrator as the falling response signal.
[0015] According to some embodiments, the slope response signal may be generated by generating a signal indicating a positive slope of the relative temperature signal and multiplying the signal indicating the positive slope of the relative temperature signal by a slope gain value to generate the slope response signal, or applying a predetermined function to the signal indicating the positive slope of the relative temperature signal to generate the slope response signal. According to some embodiments, the signal indicating the positive slope of the relative temperature signal may be generated by providing the relative temperature signal to a high pass filter (HPF) and providing the output of the HPF to a rectifier to generate the signal indicating the positive slope of the relative temperature signal. Alternatively, the difference between two temporally different samples of the relative temperature signal may be determined, and the signal indicating the positive slope of the relative temperature signal may be determined based on the difference.
[0016] According to certain embodiments, an implantable medical system includes, among other things, one or more pulse generators, one or more electrodes, a temperature sensor, and a controller. The pulse generator(s) are configured to selectively generate pacing pulses. The electrodes(s) are configured to deliver the pacing pulses generated by the pulse generator(s) to the heart of the patient in which the implantable medical system is implanted. The temperature sensor is configured to generate a blood temperature signal indicating the core body temperature of the patient in which the implantable medical system is implanted. The controller generates a relative temperature signal based on the blood temperature signal, generates a moving baseline temperature signal based on the relative temperature signal, and generates a proportional response signal based on the relative temperature signal and the moving baseline temperature signal. The controller is also configured to generate a sensor-indicated rate response signal based on the proportional response signal and the basic rate, and control the delivery of pacing pulses based on the sensor-indicated rate response signal, thereby controlling the pacing rate. The controller may also be configured to generate a drop response signal and / or a slope response signal, and also generate a sensor-indicated rate response signal based on the drop response signal and / or the slope response signal. During the initial drop of the blood temperature signal that occurs during the initiation of activity, the drop response signal provides an increase in the pacing rate. During a rise in the blood temperature signal after an initial drop in the blood temperature signal, the slope response signal provides an increase in the pacing rate based on the slope of the relative temperature signal. In a specific example implementation, the controller generates a sensor-indicated rate response signal based on a combination of the proportional response signal, the falling response signal, the slope response signal, and the basal rate.
[0017] This summary is not intended to be a complete description of the technology or to limit its scope.Alternative and additional features, aspects, and objects of the technology may be obtained from a review of the specification, drawings, and claims. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] The novel features of the present technology are particularly set forth in the claims. A better understanding of the features and advantages of the present technology may be obtained by reference to the following detailed description setting forth illustrative embodiments in which the principles of the present technology are utilized, and the following drawings:
[0019] Figure 1A is a simplified diagram of an embodiment of a leadless cardiac pacemaker.
[0020] Figure 1B is a schematic block diagram showing the interconnection of operating elements of an illustrative rate-responsive leadless cardiac pacemaker embodiment.
[0021] Figure 2A , Figure 2B and Figure 2C Three embodiments of temperature sensors in leadless cardiac pacemakers are shown.
[0022] Figure 3 is a block diagram of an embodiment of a temperature-responsive controller.
[0023] Figure 4A is a graph showing how relative temperature sensed using an implanted temperature sensor changes over time.
[0024] Figure 4B is a graph illustrating how an exemplary falling response, an exemplary slope response, and an exemplary proportional response may be combined with each other, and with a base rate, to produce a sensor indicated rate (SIR) response.
[0025] Figure 5 is a high-level flow chart summarizing a method according to various embodiments of the present technology that may be used to provide a temperature-based rate response for a patient in which an implantable medical device (IMD) such as a Figure 1A and Figure 1B The leadless pacemaker introduced in.
[0026] Figure 6 A block diagram is shown for implementing a rate response process according to various embodiments herein.
[0027] Figure 7 is a simplified diagram of an embodiment of an intracardiac medical device (ICMD).
[0028] Figure 8 is a simplified diagram of an embodiment of an implantable stimulation device in electrical communication with one or more leads implanted in a patient's heart for sensing the patient's condition, delivering therapy to the patient, or some combination thereof.
[0029] Fig. 9 is a simplified diagram illustrating an example of a cardiac rhythm management system formed in accordance with certain embodiments herein.
[0030] According to common practice, the various features shown in the figures may not be drawn to scale. Therefore, the dimensions of the various features may be arbitrarily expanded or reduced for clarity. In addition, some of the drawings may be simplified for clarity. Therefore, the drawings may not depict all components of a given device or method. Finally, similar reference numerals may be used to represent similar features throughout the specification and drawings. DETAILED DESCRIPTION
[0031] Embodiments of the present technology will be described below with reference to detailed illustrative embodiments. Obviously, the embodiments described herein can be embodied in a variety of forms, some of which may appear to be very different from the disclosed embodiments. Therefore, the specific structural and functional details disclosed herein are representative only and do not limit the scope of the present technology. For example, based on the teachings of this article, it should be understood by those skilled in the art that the various structural and functional details disclosed herein can be incorporated into the embodiments independently of any other structural or functional details. Therefore, any number of structural or functional details set forth in any disclosed (one or more) embodiments can be used to implement the device or practice method. In addition, as a supplement or replacement for the structural or functional details set forth in any disclosed (one or more) embodiments, other structural or functional details can also be used to implement the device or practice method.
[0032] The present disclosure relates to cardiac rhythm management systems that are responsive to temperature. The cardiac rhythm management system may include one or more implantable medical devices, including but not limited to: a leadless cardiac pacemaker that can be implanted in a chamber of the patient's heart; an intracardiac implantable medical device that utilizes an IC device extension to provide dual chamber functionality; a cardiac pacemaker and / or implantable cardioverter defibrillator (ICD) that utilizes one or more conductive leads that pass through blood vessels and cardiac chambers to connect a canister with electronics and a power source (canister) to electrodes attached to the heart for the purpose of electrically stimulating cardiac tissue and measuring myocardial electrical activity; a subcutaneous ICD that does not use endocardial, transvenous, or epicardial leads to deliver defibrillation (but may use endocardial, transvenous, or epicardial leads to sense temperature) and may use subcutaneous electrodes to deliver defibrillation; a temperature sensor implanted in the patient's heart or associated blood vessels; an intracardiac monitor that includes a temperature sensor, which may be a stand-alone device or part of a lead; a master device, programmer, or implantable cardiac monitor that does not pace the heart itself, which may contain a processor that analyzes temperature and provides a sensor-indicated rate and communicates with another implantable medical device of the cardiac rhythm management system.
[0033] In certain embodiments, the temperature sensor and / or the processor that analyzes the temperature and provides the sensor indication rate may employ a micromechanical system ("MEMS"), such as the MEMS described in U.S. Patent No. 8,573,062. The MEMS may be a stand-alone device that, in some embodiments, is implanted in the epicardium or cardiac chamber of the heart, for example, by securing the device directly to the myocardium using spiral wires and sutures, such as described in U.S. Patent No. 7,937,148. In embodiments that do not include a temperature sensor, the MEMS stand-alone device may be implanted elsewhere in the body. The MEMS may be configured to communicate with the stimulation device via wireless communication, such as via conductive communication as described in U.S. Patent No. 9,168,383, such as by incorporating a communication pulse generator. In an alternative embodiment, the MEMS is incorporated into an implantable lead and may communicate with the stimulation device via wired communication.
[0034] Some embodiments of a leadless cardiac pacemaker can include a sealed housing placed in a human heart chamber, a battery placed in the housing, at least two electrodes supported by the housing, a temperature sensor enclosed or contained in the housing, and a controller placed in the housing. The controller can be adapted to sense intracardiac information using the two electrodes and deliver stimulation energy from the battery to the electrodes using temperature information from the temperature sensor. The temperature sensor can be a thermistor or a semiconductor temperature sensor incorporated into the controller.
[0035] Figure 1A An external view of a leadless pacemaker or biostimulator 100 is shown. The biostimulator 100 can include a sealed housing 102 with electrodes 104 and 106 located within, on, or near the housing 102 for delivering pacing pulses to and sensing electrical activity from muscles of a heart chamber, and for bidirectional communication with at least one other device inside or outside the body. In various embodiments, the electrodes 104 and 106 can be coupled on, inside, or within two centimeters of the housing 102. In alternative embodiments, the electrodes 104 and 106 can be coupled on, inside, or within fifteen centimeters of the housing 102. In some arrangements, the electrodes 104 and 106 can be integrally formed on an outer surface of the housing 102.
[0036] As shown, electrode 106 can be separate from but partially surrounded by fixation mechanism 105, and electrode 104 can be placed on housing 102. Fixation mechanism 105 can be a fixation spiral, a plurality of hooks, barbs, or other attachment features configured to attach the pacemaker to tissue, such as cardiac tissue.
[0037] The housing may also include an electronics compartment 110 within the housing that contains electronic components necessary for the operation of the pacemaker, including, for example, a pulse generator, communication electronics, a battery, and a processor for operation. The sealed housing 102 may be adapted to be implanted on or in a person's heart, and may be, for example, cylindrical, rectangular, spherical, or any other suitable shape.
[0038] The housing can include a conductive, biocompatible, inert, and anodically safe material, such as titanium, 316L stainless steel, or other similar material. The housing can also include an insulator disposed on the conductive material to separate electrodes 104 and 106. The insulator can be an insulating coating on the portion of the housing between the electrodes and can include a material such as silicone, polyurethane, parylene, or another biocompatible electrical insulator commonly used in implantable medical devices. Figure 1A In some embodiments, a single insulator 108 is disposed along the portion of the housing between electrodes 104 and 106. In some embodiments, the housing itself may include an insulator rather than a conductor, such as alumina ceramic or other similar material, and the electrodes may be disposed on the housing.
[0039] like Figure 1A As shown, the pacemaker may also include a stem assembly 112 to insulate the electrode 104 from the electrode 106. The stem assembly 112 may be made of PEEK, tecothane, or another biocompatible plastic, and may include a ceramic to metal feedthrough, a glass to metal feedthrough, or other suitable feedthrough insulators known in the art.
[0040] Electrodes 104 and 106 may comprise pacing / sensing electrodes, or return electrodes. Low polarization coatings may be applied to the electrodes, such as, for example, sintered platinum, platinum iridium, iridium, iridium oxide, titanium nitride, carbon, or other materials commonly used to reduce polarization effects. Figure 1A In the embodiment of the present invention, electrode 106 can be a pacing / sensing electrode and electrode 104 can be a return electrode. Electrode 104 can be a portion of conductive housing 102 that does not include insulator 108.
[0041] Several techniques and structures can be used to attach the housing 102 to the inner or outer wall of the heart. The helical fixation mechanism 105 can enable the device to be inserted into the heart or outside the heart through a guide catheter. The twistable catheter can be used to rotate the housing and force the fixation device into the heart tissue, thereby placing the fixation device (and Figure 1A Electrode 106 in the device is attached to contact the stimulable tissue. Electrode 104 can act as a neutral electrode for sensing and pacing. The fixing mechanism can be partially or fully coated to achieve electrical insulation and a steroid eluting matrix can be included on or near the device to minimize fibrotic response, which is known in traditional pacing electrode leads.
[0042] Go to Figure 1B , a schematic block diagram depicts an embodiment of a biostimulator 100. The biostimulator 100 includes a housing 102, electrodes 104 and 106 connected to the housing 102, and a pulse delivery system 152 sealed within the housing 102 and electrically connected to the electrodes 104 and 106. The pulse delivery system 152 is configured to harvest energy within the housing 102, generate and provide electrical pulses to the electrodes 104 and 106. The biostimulator 100 also includes a temperature sensor 154, which can be enclosed within the housing 102 or can be supported by the housing 102 and is suitable for sensing temperature. Logic 120 (e.g., a processor, controller, central processing unit, state machine, programmable logic array, etc.) is sealed within the housing 102 and is communicatively coupled to the pulse generator 116, the temperature sensor 154, and the electrodes 104 and 106. The logic 120 can control the pulse generator 116 to deliver electrical pulses having an amplitude, pulse width, frequency, or electrode polarity specified by one or more selected treatment programs stored in a memory. The temperature sensor 154 is connected to the evaluator 186. Figure 2A , Figure 2B and Figure 2C An exemplary embodiment of the temperature sensor 154 is discussed. However, other types of temperature sensors may also be selected for use. According to certain embodiments of the present disclosure, the evaluator 186 is used to provide a sensor-indicated rate for cardiac pacing. The evaluator 186 is connected to the logic 120. The sensor-indicated rate output of the evaluator 186 is used by the logic 120 to generate a control signal specifying a stimulation therapy (such as a pacing rate) and send it to the pulse generator 116.
[0043] Therefore, logic 120 and other blocks can be implemented by software, firmware or a combination thereof. The software module can reside in a RAM memory, a flash memory, a ROM memory, an EPROM memory, an EEPROM memory, a register or any other form of storage medium known in the art. An exemplary storage medium is coupled to a processor so that the processor can read information from the storage medium and write information to the storage medium. In an alternative case, the storage medium can be integrated into the processor. In some embodiments, logic 120 includes an application specific integrated circuit (ASIC), and temperature sensor 154 includes a semiconductor temperature sensor incorporated into the ASIC. Evaluator 186 and storage medium can reside in the ASIC. In some embodiments, logic 120 can include a single ultra-low power ASIC chip configured to sense, pace and communicate. Logic 120 can control electrical pulse delivery based at least in part on the output of evaluator 186.
[0044] In some embodiments, the logic 120 can be a processor that controls the delivery of electrical pulses and the application of the temperature sensor 154 and the evaluator 186 according to one or more programmable parameters, which can be programmed by communication signals transmitted via the electrodes 104 and 106. The information communicated on the incoming communication channel can include, but is not limited to, pacing rate, pulse duration, sensing threshold and other parameters that are usually externally programmed in a typical pacemaker, and a temperature signal generated by an external temperature sensor. The information communicated on the outgoing communication channel can include, but is not limited to, programmable parameter settings, event counts (pacing and sensing), battery voltage, battery current and other information that is usually displayed by an external programmer used by ordinary pacemakers, and temperature signals. The outgoing communication channel can also echo information from the incoming channel to confirm correct programming. The logic 120 and the evaluator 186 can be referred to as a controller alone or in combination. Such a controller can include one or more processors, software, firmware, hardware or a combination thereof.
[0045] Sealed feedthroughs 130, 131 conduct electrode signals through housing 102. Housing 102 contains a main battery 114 that provides power for pacing, sensing, and communications. Housing 102 contains: circuitry 132 for sensing cardiac activity from electrodes 104 and 106; circuitry 134 for receiving information from at least one other device via electrodes 104 and 106; and a pulse generator 116 for generating pacing pulses for delivery via electrodes 104 and 106 and also for transmitting information to at least one other device via electrodes 104 and 106. Pacemaker 100 also contains circuitry for monitoring device health, such as a battery current monitor 136 and a battery voltage monitor 138. Logic 120 controls these operations in a predetermined manner.
[0046] The main battery 114 has a positive terminal 140 and a negative terminal 142. In certain embodiments, the battery is a lithium monofluoride carbon (Li / CFx) battery. Current from the positive terminal 140 of the main battery 114 flows through a shunt 144 to a voltage regulation circuit 146 to create a positive voltage supply 148 suitable for powering the remaining circuits of the pacemaker 100. The shunt 144 enables the battery current monitor 136 to provide an indication of battery current depletion to the logic 120 and indirectly provide an indication of device health.
[0047] In various embodiments, the system can manage power consumption to extract limited power from the battery, thereby reducing the size of the device. Each circuit in the system can be designed to avoid large peak currents. For example, cardiac pacing can be achieved by discharging a tank capacitor (not shown) across the pacing electrode. The recharging of the tank capacitor is usually controlled by a charge pump circuit. In a specific embodiment, the charge pump circuit is throttled to recharge the tank capacitor at a constant power from the battery.
[0048] exist Figure 2A In an embodiment, a temperature sensor (e.g., Figure 1B 154) can be a thermistor 226 disposed within the housing 200. As shown in the cross-sectional view, the thermistor 226 can be bonded so as to be thermally connected to the inner surface of the housing 200, and the thermistor can be connected to the ASIC controller 220 via leads 228 and substrate 224. Thus, the thermistor 226 can be configured to sense the temperature of the blood surrounding the biostimulator through the housing 200. Other elements within the housing 200 include an ASIC substrate 224, other electronic components 222, and a battery (not shown). At least two electrodes can be supported by the housing and outside the housing. In some embodiments, the ASIC 220 can be adapted to sense intracardiac information using electrodes and deliver stimulation energy from the battery to one of the electrodes using temperature information from the thermistor 226.
[0049] exist Figure 2B In an embodiment, a temperature sensor (e.g., Figure 1B 154) may be a semiconductor temperature sensor integrated into ASIC 224. Thermal conductive pad 225 may extend from the temperature sensor in ASIC 224 to the inner surface of housing 200. Thus, the temperature sensor may sense the temperature of the blood around the biostimulator through housing 200 with conductive pad 225. Figure 2A In an embodiment, at least two electrodes may be supported by the housing and external to the housing. The ASIC controller 220 may be adapted to sense intracardiac information using the electrodes and deliver stimulation energy from the battery to one of the electrodes using temperature information from the integrated temperature sensor.
[0050] Figure 2C Examples and Figure 2B 224, but omits the thermal pad. Figure 1B 154) senses the blood temperature surrounding the biostimulator via thermal conduction between the ASIC 224 and the tank 202. Also, in this embodiment, the ASIC controller 220 can be adapted to sense intracardiac information using electrodes and deliver stimulation energy from the battery to one of the electrodes using temperature information from the incorporated temperature sensor.
[0051] Steering Figure 3 According to some embodiments of the present disclosure, the block diagram shows an evaluator 186 (in Figure 1B ) for providing a sensor indicating rate for cardiac pacing. Figure 3In the description of FIG. 1 , it is assumed that the components shown therein (e.g., filters, accumulators, integrators, etc.) are implemented in the digital domain using digital circuits, software, and / or firmware. However, it should be noted that in alternative embodiments of the present technology, evaluator 186 may be implemented using analog components. Nevertheless, unless otherwise stated, it is assumed that Figure 3 The components shown and described in are implemented in the digital domain. In the embodiments described herein, it is assumed that the blood temperature measured by the temperature sensor is the same or substantially the same as the core body temperature. Therefore, the terms blood temperature and core body temperature can be used interchangeably.
[0052] Relative Temperature
[0053] Reference Figure 3 , blood temperature signal 350 is provided from the temperature sensor to the inputs of low pass filters 302 and 303 of evaluator 186. Logic 120 (at Figure 1B 186) controls the time interval at which the blood temperature signal detected by the temperature sensor is sampled by the evaluator 186. In this illustrative embodiment, the sampling interval at which the blood temperature signal is sampled is 5 seconds. However, sampling intervals greater than or less than five seconds are also possible and within the scope of the embodiments described herein.
[0054] A low pass filter (LPF) 302 provides a short term average (STA) of the blood temperature signal 350 to a non-inverting (+) input of an adder 304, which may also be referred to as an accumulator 304. The non-inverting (+) input of the adder 304 may also be referred to as a positive input of the adder 304. In this example, the time constant of the LPF 302 is 0.33 minutes. The LPF 302 is intended to remove noise from the blood temperature signal, where changes in blood temperature with intervals shorter than 0.33 minutes are attributed to noise rather than motion or other activity. The LPF 302 also increases the effective resolution of the temperature measurement. The LPF 302 may be a first order low pass filter, but is not limited thereto. It is possible to use a shorter or longer time constant for the LPF 302 and is within the scope of the embodiments described herein.
[0055] The LPF 303 provides the long term average (LTA) of the blood temperature signal 350 to the inverting (-) input of the adder 304. The inverting (-) input of the adder 304 may also be referred to as the negative input of the adder 304. In some embodiments, the time constant of the LPF 303 is 85 minutes. The output of the LPF 303 is intended to track the baseline blood temperature in the absence of exercise or other activity, where changes in blood temperature at intervals longer than 85 minutes are attributed to factors such as fever, diurnal variations, and measurement drift, rather than exercise or other activity. Therefore, the LTA of the blood temperature signal (which is output by the LPF 303) may also be referred to as the baseline blood temperature. It will be appreciated that other non-exercise factors may represent sources of longer term time constant variations. It is possible to use shorter or longer time constants for the LPF 303 and is within the scope of the embodiments described herein.
[0056] The adder 304 outputs a relative temperature signal 351, which represents the current blood temperature relative to the baseline value before exercise or other activities. More specifically, the adder 304 is used to generate a relative temperature signal 351 by subtracting LTA (generated by LPF 303) from STA (generated by LPF 302). This relative temperature signal 351 is to exclude noise and non-exercise factors such as fever, diurnal variation and measurement drift. When a person is at rest and his short-term average (STA) temperature is the same as his long-term average (LTA) temperature, his relative temperature 351 will be zero. When a person starts to exercise and his core body temperature initially drops, the relative temperature 351 will initially become negative, that is, below zero. After a long period of exercise, the person's core body temperature will eventually rise, making its STA greater than its LTA, at which time the relative temperature will become a positive number, that is, above zero.
[0057] Figure 3 Illustration 307 of provides details of an exemplary embodiment of a low pass filter (LPF) of the evaluator 186. In the example of illustration 307, the LPF is implemented as a linear first order recursive digital filter. The time constant of the filter is similar to the time constant of a resistor-capacitor (RC) electrical filter, which is approximately α (alpha) times the sampling interval (5 seconds). Illustration 307 can implement any LPF of the evaluator 186 in this example embodiment. The LPF shown in illustration 307 is a relatively simple single pole filter. In alternative embodiments, a more complex multi-pole LPF may be used instead, as will be appreciated by one of ordinary skill in the art.
[0058] In summary, the relative temperature signal 351 provides a signal representative of the change in blood temperature due to exercise or other activity, which is then communicated to the input of the three parts of the evaluator 186: the drop response, the slope response, and the proportional response. Explained in another way, the relative temperature signal 351 is provided to the drop response branch 310, the slope response branch 320, and the proportional response branch 330. As can be seen from Figure 3 As will be appreciated in the foregoing and described in further detail below, according to certain embodiments, the outputs (also referred to as signal outputs) of each of these branches 310, 320, and 330 are combined (e.g., summed by accumulator 324) to produce a rate adjustment output 357 (also referred to as rate adjustment signal 357), which is used to produce a sensor indicated rate response signal 358. Additional details of each branch 310, 320, and 330 of evaluator 186 will now be described.
[0059] Drop response
[0060] When a person changes from an inactive or resting state to an active state, the person's core body temperature will typically drop from a baseline or first core body temperature to a second core body temperature. In other words, the person's core body temperature will typically initially have a small drop. This small drop in the person's core body temperature is caused by vasodilation at the start or expected location of exercise or other activity. Explained in another way, the small drop at the beginning of exercise is due to the flow of cooler blood to the heart from the body's surroundings where the blood is cooler. The initial drop in core body temperature (also referred to as a drop) is usually followed by a rise in core body temperature, or by a short leveling off period followed by a rise in core body temperature. If the activity is short-lived, the core body temperature will typically slowly return to its baseline core body temperature. However, if the activity (such as exercise) continues, the core body temperature will rise above the baseline core body temperature to an elevated core body temperature, which will typically continue to rise until a maximum value is reached or the activity stops. After the activity stops, the core body temperature will typically slowly return to the baseline core body temperature.
[0061] Embodiments of the present technology utilize a drop response to take into account the fact that a person's core body temperature typically experiences a drop at the onset of activity (e.g., exercise). According to certain embodiments of the present technology, Figure 3 The down response branch 310 shown in FIG. 3 illustrates the implementation of the down response.
[0062] refer to Figure 3In this illustrative embodiment, the falling response is implemented by a comparator 341 and an integrator 343 included in the falling response branch 310 of the evaluator 186. The comparator 341 is shown as including an inverting (-) input and a non-inverting (+) input (also referred to as a negative input and a positive input, respectively) and an output. The inverting (-) input of the comparator 314 is provided with a relative temperature signal 351, and the non-inverting (+) input of the comparator 314 is provided with a falling threshold 311 stored, for example, in a register or some other storage element. An exemplary value for the falling threshold is -0.06 degrees Celsius (°C), but a higher or lower falling threshold may also be selected. A switch 342 controlled by the output of the comparator 341 provides a falling start rate value 312 (e.g., 4.8 bpm / min) to the input of the integrator 343, or provides a falling decay rate value 313 (e.g., -1.6 bpm / min) to the input of the integrator 343. Each of the drop start rate value 312 and the drop decay rate value 313 can be stored in a respective register or some other storage element. In addition to the exemplary values specified above, other drop start rate values 312 and drop decay rate values 313 can also be used. Each of the drop threshold 311, the drop start rate 312, and the drop decay rate 313 can be programmable and stored in respective registers or memory locations so that they can be customized by a particular person.
[0063] When the amplitude of the relative temperature signal 351 is greater than the falling threshold (e.g., -0.06°C), the output of the comparator will be LOW, and the switch 342 will be controlled to provide the falling decay rate (e.g., -1.6 bpm / min) to the integrator 343. When the amplitude of the relative temperature signal 351 transitions to less than the falling threshold (e.g., -0.06°C), which indicates the start of motion, the output of the comparator will be HIGH, and the switch 342 will be controlled to provide the falling start rate 312 (e.g., 4.8 bpm / min) to the input of the integrator 343.
[0064] Integrator 343 is configured to integrate a signal received at its input, which is a falling start rate 312 or a falling decay rate 313 selected by switch 342, which is controlled by the output of comparator 341. According to some embodiments, integrator 343 is configured to generate an output only when its integration result is positive. Alternatively, integrator 343 can generate both positive and negative outputs at the same time, and a rectifier (e.g., similar to rectifier 322 discussed below) can receive the output of integrator 343 so that only the positive component of the output of integrator 343 is provided to accumulator 324. In either case, the falling response signal 356 generated by the falling response branch 356 should be a positive signal or zero. Since integrator 343 is part of the falling response branch 310, it can also be more specifically referred to as falling integrator 343.
[0065] like Figure 3 As shown, the drop response signal 356 generated by the drop response branch 310 is provided to the accumulator 324, which accumulates the drop response signal 356 with the slope response signal 353 and the proportional response signal 354 (generated by branches 320 and 330, respectively) to produce a rate adjustment signal 357. The rate adjustment signal 357 is added to the basic rate 317 to produce a sensor indication rate 358, which will be described in detail below. According to certain embodiments, the integrator 343 is configured so that its output cannot exceed the maximum drop response, for example, 30bpm, to limit the amount by which the sensor indication rate 358 can increase in response to the start of movement. The maximum drop 314 can be stored in a register or some other storage element and can be programmable so that it can be customized by a particular person.
[0066] As described above, when the relative temperature 351 drops below the drop threshold 311, the drop integrator 343 ramps up at the drop start rate. The integrator 343 will stop at the level set by the maximum drop 314. According to certain embodiments, when the drop subsides, so that the relative temperature 351 is above the drop threshold 311, the comparator 341 and the switch 342 will cause the drop decay rate 313 (rather than the drop start rate 312) to be provided to the input of the drop integrator 343, and the drop integrator 343 will linearly decay the output of the integrator at the drop decay rate 313 (e.g., -1.6 bpm / min) until the final drop response 356 will return to zero. In another embodiment, the output of the integrator 343 can increase and / or decrease non-linearly.
[0067] The descent integrator 343 preferably provides a gradual increase in the descent response 356 in response to the initiation of exercise. In addition, the descent integrator 343 preferably maintains the descent response 356 above zero for a period of time after the initiation of exercise and provides an increase in heart rate during prolonged descents.
[0068] According to some embodiments, a high pass filter (HPF) may be included in the falling response branch 310 to filter the relative temperature signal 351 before providing it to the inverting (-) input of the comparator. Such an added HPF may have an exemplary time constant of 10 minutes, but is not limited thereto. The purpose of adding the HPF is to limit the time range of the falling response.
[0069] Slope response
[0070] The slope response 353 provided by the slope response branch 320 is intended to provide a short-term response during the rise in relative temperature 351 within a few minutes of exercise, following an initial drop in relative temperature. Figure 3 , in the embodiment shown therein, the slope response branch 320 is shown to include a high pass filter (HPF) 321, a rectifier 322, and a multiplier 323. The HPF 321 may be replaced by a band pass filter (BPF), in which case such a BPF may also be implemented by a combination of an LPF and an HPF.
[0071] When the relative temperature 351 is increasing, this indicates that exercise is warming the blood, and the rate at which the temperature rises (i.e., the slope) is an indication of the level of exercise. The HPF 321 essentially acts as a slope detector, so that its output indicates the slope of the relative temperature signal 351. A rectifier 322 is downstream of the HPF 321, which only passes positive slope values to the multiplier 323 and provides zero to the multiplier 323 when the slope value is negative. The multiplier 322 multiplies the positive slope value output by the HPF 321 by the slope gain 315 to provide the slope response 353. An example value for the slope gain 315 is 320 bpm per minute per degree Celsius (bpm / ℃ / min), but higher and lower values can be used. The slope gain 315 can be stored in a register or some other storage element, and can be programmable so that it can be customized by a particular person. In another embodiment, rather than multiplying the positive slope value by the slope gain (315) to produce a slope gain response, a predetermined function may be applied to the positive slope value to produce the slope response signal 353. An example of such a function is a piecewise function having two parts, including a first part having an initial slope of 320 bpm / °C / min, and a second part having a slope of 160 bpm / °C / min (e.g., for relative temperature values greater than 0.1°C). Other variations are possible and are within the scope of the embodiments described herein.
[0072] Based on alternative embodiments, alternative types of slope detectors may be used in place of HPF 321. For example, an alternative slope detector may determine the difference between two values of relative temperature 351 and divide the difference in values by the difference in sampling times corresponding to the two values. Other techniques for detecting slope are possible and are known to those of ordinary skill in the art and are within the scope of the embodiments disclosed herein.
[0073] As long as relative temperature 351 is increasing, slope response 353 should have a positive value and will contribute to rate adjustment 357. However, when relative temperature 351 is not increasing, slope response 353 should be zero and will not contribute to rate adjustment 357.
[0074] Proportional response
[0075] The proportional response generated by proportional response branch 330 is calculated by subtracting moving baseline 352 from relative temperature 351. Figure 3 , the long term average temperature output by LPF 303 may also be referred to as a baseline temperature because it indicates a baseline core body temperature over a relatively long period of time (e.g., 85 minutes). In contrast, within proportional response branch 330, a moving baseline temperature 352 is generated that follows the downward drop in relative temperature 351. When the drop is complete, the moving baseline is allowed to gradually return to zero in a linear or nonlinear manner. This quantity represents a body core temperature baseline that takes into account the drop in core body temperature caused only by the drop in the surroundings. In other words, it is the core temperature in the absence of exercise or other activity.
[0076] Still reference Figure 3 , the proportional response branch 330 is shown to include an accumulator 305, a follow / decay to zero block 306, a rectifier 331, and a multiplier 332. The relative temperature 351 is provided to the positive input of the accumulator 305 and to the block 306. According to an embodiment, the output of the block 306 (i.e., the moving baseline temperature 352) follows the relative temperature 351 during the falling period of the relative temperature 351 and is provided to the negative input of the accumulator 305. As long as the relative temperature is falling and is negative, the output of the accumulator 305 will be zero. For example, if the relative temperature is -0.01, then the output of the block 206 will also be -0.01, in which case the accumulator 305 will perform the calculation sum = -0.01-(-0.01) = -0.01+0.01 = 0. Once the relative temperature begins to increase (after reaching a minimum, i.e., a maximum drop), the moving baseline temperature 352 will lag the relative temperature signal, and the output of the accumulator 305 will remain positive for at least a portion of the time that the patient remains active as the moving baseline temperature 352 decays toward zero.
[0077] The accumulator 305 subtracts the moving baseline temperature signal 352 from the relative temperature signal 351 to produce a difference signal indicating the difference between the relative temperature signal and the moving baseline temperature signal. A rectifier 331 is downstream of the accumulator 305, which passes only the positive slope value of the difference signal to the multiplier 332 and provides zero to the multiplier 332 when the difference signal is negative. The multiplier 332 multiplies the positive difference value output by the accumulator 305 by the proportional gain 316 to provide a proportional response 354. An example value of the proportional gain 316 is 50 bpm / ℃ / min, but higher and lower values can also be used. The proportional gain 316 can be stored in a register or some other storage element and can be programmable so that it can be customized by a particular person. In an alternative embodiment, instead of multiplying the positive difference value by the proportional gain (316) to produce a proportional response, a predetermined function is applied to the positive difference value to produce a proportional response signal 354. An example of such a function is a piecewise function with two parts, including a first part with an initial slope of 50 bpm / °C / min, and a second part with a slope of 25 bpm / °C / min (e.g., for relative temperature values greater than 0.2°C). Other variations are possible and are within the scope of the embodiments described herein.
[0078] Rate adjustment and sensor indicated rate
[0079] like Figure 3 As shown, the falling response 356, the slope response 353, and the proportional response 354 are accumulated by the accumulator 324 to produce a rate adjustment signal 357. The accumulator 324 adds the basic rate (e.g., 60 bpm) to the rate adjustment signal to produce a sensor indicated rate 358. The limiter 326 limits the sensor indicated rate 358 to a maximum sensor rate (e.g., 120 bpm). The slew limiter 328 limits the rate of change of the sensor indicated rate 358. The slew limiter 328 can be implemented, for example, using a low pass filter (LPF) with a short term averaging time constant of 0.33 minutes to prevent sudden changes in the pacing rate. The sensor indicated rate 358 is output to the logic 120 (at Figure 1B ), which adjusts and / or delivers therapy by sending control signals to pulse generator 116 to produce pacing pulses delivered via electrodes 104 and 106. In some embodiments, the pacemaker may use the sensor-indicated rate to adjust the pacing rate.
[0080] Although logic 120 and evaluator 186 are shown as Figure 1B Although logic 120 and evaluator 186 are separate modules, logic 120 and evaluator 186 may be incorporated into a single processing unit. Evaluator 186 and any of its components discussed in more detail herein may be components of logic 120 or modules executed by logic 120.
[0081] The slope gain 315, proportional gain 316, maximum drop 314, and / or maximum sensor rate 318 may be pre-programmed with default values based on the patient's age and / or health. Such values may be customized for a particular patient based on the "Wilkoff model" or some other appropriate physiological motion spatiotemporal response model for providing an appropriate predicted heart rate for a given exertion level for a particular patient. Heart rates appropriate for a variety of exertion levels may be derived from the model by the biostimulator 100, or by a programmer that communicates with and programs the biostimulator 100, and may be stored in the biostimulator or programmer as a table or the like. The biostimulator 100 may then be programmed to record a heart rate curve over time, as well as an exertion level curve determined from an exertion level sensor such as an accelerometer or minute ventilation sensor. By comparing the recorded heart rate curve to the predicted heart rate from the model, the biostimulator may determine if and when a change in chronotropic state has occurred.
[0082] Example Graphics
[0083] The falling response signal 356, the slope response signal 353, and the proportional response signal 354 may be more concisely referred to as falling response 356, slope response 353, and proportional response 354, respectively. Likewise, the rate adjustment signal 357 may be more concisely referred to as rate adjustment 357, and the sensor indication rate signal 358 may be more concisely referred to as sensor indication rate 358.
[0084] Figure 4A and 4B is an exemplary graph for showing a drop response 356, a slope response 353, and a proportional response 354 (each of which is initially referred to above). Figure 3 discussed) together contribute to producing rate adjustment 357 and sensor-indicated rate 358 for an exemplary person.
[0085] Figure 4A shows how the relative temperature 351 sensed using an implanted temperature sensor changes over time. More specifically, Figure 4A It shows that at the onset of exercise or other activity, there is an initial small drop in relative temperature 351, followed by an increase in relative temperature 351, followed by a brief plateau, and then a slow or gradual return to zero. Figure 4A It also illustrates how the drop response 356 , the slope response 353 , and the proportional response 354 contribute to the production rate adjustment 357 and the sensor indicated rate 358 at different time periods. Figure 4B An exemplary falling response 356, an exemplary slope response 353, and an exemplary proportional response 354 are shown, and how the above responses can be added together (in Figure 3324 in the summing node 324) to produce an exemplary rate adjustment 357, and how the rate adjustment 357 is added to the base rate 317 (in Figure 3 The summing node 325 in FIG. 3 is used to generate an exemplary sensor indication rate (SIR) 358. Figure 4A and 4B In the example, it is assumed that the maximum sensor rate of 318 is not exceeded. In addition, it should be noted that Figure 4A and 4B The waveforms in are not drawn to scale, but serve as illustrative examples of how embodiments of the present technology combine the three responses with the base rate 325 to produce a sensor indication rate (SIR) 358.
[0086] Reference Figure 4A , the relative temperature 351 is shown starting at 0.00°C at time t0, and then dropping to the falling threshold 311 at time t1. The relative temperature 351 is shown to continue dropping until time t2, at which it begins to rise until increasing to the falling threshold at time t3. Due to continued exercise or other activity, the relative temperature 351 continues to rise until it reaches a plateau at time t5, which may correspond to the point at which the person stops exercising or otherwise rests. Between time t5 and t6, the relative temperature 351 is shown to drop until it reaches 0.00°C at time t6. Figure 4A It also shows the Figure 3 0046. An example of a moving baseline temperature 352 output by block 306 in FIG.
[0087] Reference Figure 4B In response to integrating the decline start rate 312 (by integrator 343) when the relative temperature is below the decline threshold 311, the decline response 356 is shown rising from 0 bpm at time t1 to its maximum value between times t2 and t3. Then, in response to integrating the decline decay rate 313 (by integrator 343) when the relative temperature exceeds the decline threshold 311, the decline response 356 is shown falling from its maximum value back to 0 bpm at time t4.
[0088] exist Figure 4B , the slope response 353 is shown as increasing from a point at time t2 where the relative temperature has a positive slope until the relative temperature levels off at time t5.
[0089] exist Figure 4B , the proportional response 354 is shown rising from 0 at time t2 until time t5, and then decaying back to 0 at time t6 at a decaying rate (eg, 0.02°C / minute).
[0090] exist Figure 4BIn the example, the rate adjustment 357 is generated by summing the falling response 356, the slope response 353 and the proportional response 354 (given by Figure 3 The sensor indicated rate 358 is generated by adding the rate adjustment 357 to the base rate (e.g., 60 bpm). As described above, it is assumed that the maximum sensor rate 318 is not exceeded. Although Figure 4B Not specifically shown, the upward and downward slopes of the sensor indication rate 358 may be reduced (ie, made shallower) by the transition limiter 328 .
[0091] method
[0092] Figure 5 is a high-level flow chart summarizing a method according to various embodiments of the present technology that can be used to provide a temperature-based rate response to a patient in which an implantable medical device (IMD) such as a biostimulator 100 or more generally an implantable medical system is implanted. The method described in conjunction with the flow charts (also referred to as flow charts) presented herein can be implemented, for example, in a non-transitory computer-readable medium that includes instructions for causing a programmable processor to perform the method. The instructions can be implemented as one or more software modules that can be executed by themselves or in combination with other software.
[0093] Reference Figure 5 , step 502 involves sensing a blood temperature signal indicative of the core body temperature of the patient in which the IMD is implanted. Returning briefly to Figure 3 , wherein the blood temperature signal 350 shown is an example of a blood temperature signal that can be sensed in step 502. The blood temperature signal can be sampled, for example, at a sampling interval of five seconds. However, sampling intervals greater than or less than five seconds are also possible and within the scope of the embodiments described herein. Exemplary temperature sensors that can be used to sense the blood temperature signal have been described above.
[0094] Reference again Figure 5 , step 504 involves generating a relative temperature signal based on the blood temperature signal. Figure 3 , wherein the relative temperature signal 351 shown is an example of a relative temperature signal that may be generated in step 504. According to some embodiments, the relative temperature signal may be generated by generating a short-term average (STA) of the blood temperature signal, generating a long-term average (LTA) of the blood temperature signal, and generating the relative temperature signal by subtracting the LTA of the blood temperature signal from the STA of the blood temperature signal. Figure 3As shown, STA of the blood temperature signal can be generated by LPF 302, LTA of the blood temperature signal can be generated by LPF 303, and accumulator 304 can be used to subtract LTA of the blood temperature signal from STA of the blood temperature signal to generate relative temperature signal 351.
[0095] Reference again Figure 5 , step 506 involves generating a moving baseline temperature signal based on the relative temperature signal. Figure 3 , the moving baseline temperature signal 352 is an example of a result of step 506, and block 306 may be used to generate the moving baseline temperature signal 352. According to some embodiments, the moving baseline temperature signal follows the relative temperature signal during an initial drop in the blood temperature signal that occurs during the initiation of activity, and decays toward zero during a rise in the blood temperature signal after the initial drop in the blood temperature signal.
[0096] refer to Figure 5 , step 508 involves generating a proportional response signal, a falling response signal, and a slope response signal based on the relative temperature signal. Figure 3 4, the proportional response signal 354, the falling response signal 356, and the slope response signal 353 shown therein are examples of signals generated at step 508. For further details on how such signals are generated, refer to Figure 3 4 and will be discussed below.
[0097] Reference Figure 5 , step 510 involves generating a rate adjustment signal based on the proportional response signal, the falling response signal, and the slope response signal. Figure 3 4, where rate adjustment signal 357 is shown as being generated by summing proportional response signal 354, falling response signal 356, and slope response signal 353. Alternative ways of combining the signals are possible and within the scope of the embodiments described herein.
[0098] refer to Figure 5 , step 512 involves generating a sensor indicated rate response signal based on the rate adjustment signal and the base rate. Figure 3and Figure 4, in which the sensor indication rate response signal 358 shown can be generated by summing the rate adjustment signal 357 and the basic rate 317. Alternatively, the sensor indication rate can be generated by summing the proportional response signal 354, the falling response signal 356, the slope response signal 353, and the basic rate. In other words, the step of generating the rate adjustment signal can be skipped, and instead, the proportional response signal 354, the falling response signal 356, the slope response signal 353, and the basic rate 317 can be combined (e.g., added) in a single step. Combining the proportional response signal with only one of the falling response signal 356 and the slope response signal 353 is also within the scope of the embodiments described herein. For example, only the larger of the falling response signal 356 and the slope response signal 353 can be used, or only a predetermined one of the two can be used. According to certain embodiments, for example, using Figure 3 The limiter 326 and / or 328 in the sensor indicates the amplitude and / or conversion rate of the rate response signal. Finally, Figure 5 Step 514 in involves controlling the pacing rate of the IMD based on the sensor-indicative rate response signal. This may involve, for example, increasing or decreasing the rate at which pacing pulses are generated and delivered via one or more electrodes to cause cardiac pacing in the patient.
[0099] According to some embodiments, the proportional response signal generated at step 508 is generated by subtracting the moving baseline temperature signal from the relative temperature signal to generate a difference signal indicating the difference between the relative temperature signal and the moving baseline temperature signal, and generating the proportional response signal based on a positive portion of the difference signal. In some embodiments, the proportional response signal is generated based on the positive portion of the difference signal by multiplying the positive portion of the difference signal by a proportional gain value (e.g., Figure 3 316 in ) to generate a proportional response signal. Alternatively, a predetermined function can be applied to the positive portion of the difference signal to generate a proportional response signal. Examples of such functions are discussed above.
[0100] According to certain embodiments, during a rise in the blood temperature signal following an initial drop in the blood temperature signal that occurs during the onset of activity, the proportional response signal provides an increase in the pacing rate based on the difference between the relative temperature signal and the moving baseline temperature signal. Additionally, during a drop in the blood temperature signal that occurs in response to a decrease or cessation of activity, the proportional response provides a decrease in the pacing rate based on the difference between the relative temperature signal and the moving baseline temperature signal.
[0101] According to some embodiments, the down response signal provides an increase in pacing rate during an initial drop in the blood temperature signal that occurs during the onset of activity. According to some embodiments, the down response signal is provided by increasing the relative temperature signal (e.g., Figure 3351) and the falling threshold (e.g. Figure 3 When the relative temperature signal is less than the falling threshold, the integrator (e.g. Figure 3 343) provides the starting rate of descent value (e.g. Figure 3 312 in ), and when the relative temperature signal is greater than the falling threshold, a falling decay rate value (eg Figure 3 313 in ). Then, the positive part of the signal output by the integrator can be used as the falling response signal. In some embodiments, the integrator (e.g. Figure 3 343 in can be designed to output zero when its integral result is negative. Alternatively, the output of the integrator can be provided to the rectifier so that only the positive output of the integrator contributes to the falling response signal. The previous embodiment is preferred because it avoids the "saturation (wind-up)" situation where the internal value of the integrator exceeds the limit and retains the excess value. The integrator can also be implemented by using a low-pass filter instead of a pure integrator. Then, it will behave as a "leaky" integrator, which may have some benefits.
[0102] According to some embodiments, during a rise in the blood temperature signal after an initial drop in the blood temperature signal, the slope response signal provides an increase in the pacing rate based on the slope of the relative temperature signal. According to some embodiments, the slope response signal may be generated by generating a signal indicative of a positive slope of the relative temperature signal and multiplying the signal indicative of a positive slope of the relative temperature signal by a slope gain value (e.g., Figure 3 315 in ), thereby generating a slope response signal (e.g., Figure 3 Alternatively, a predetermined function may be applied to the signal indicative of a positive slope of the relative temperature signal to generate a slope response signal. Examples of such functions are discussed above. According to some embodiments, the signal indicative of a positive slope of the relative temperature signal is generated by providing the relative temperature signal to the HPF (e.g., Figure 3 321 in ) to generate a signal indicating the slope of the relative temperature signal, and the output of the HPF is provided to a rectifier (e.g., Figure 3 322 in ) thereby generating a signal indicating a positive slope of the relative temperature signal. Alternatively, the signal indicating a positive slope of the relative temperature signal is generated by determining a difference between two temporally different samples of the relative temperature signal and generating a signal indicating a positive slope of the relative temperature signal based on the difference. Other variations are also possible and within the scope of the embodiments described herein.
[0103] Figure 6 FIG. 1 is a block diagram of a method for implementing a rate response process according to an embodiment of the present invention. By way of example, Figure 6 The blocks described in the can be implemented in one or a combination of hardware, circuits, and / or microprocessors implementing firmware and / or software instructions. As a further example, Figure 6 The blocks described in can be implemented by circuits such as in Figure 3 The general circuit described in the following may be referred to as an example. However, it is understood that Figure 6 The block diagram is not limited to Figure 3 Circuit implementation.
[0104] The blood temperature measurement signal 601 is provided by a temperature sensor and serves as an input to a preprocessing and baseline removal (PBR) block 602. The PBR block 602 is configured to perform noise reduction (e.g., filtering) on the raw measurement signal 601 and generate a relative temperature signal 603 determined or derived relative to the baseline. The relative temperature signal 603 is fed into three processing blocks, namely, a drop response 604, a slope response 606, and a proportional response 608. The drop response 604, the slope response 606, and the proportional response 608 can be implemented in parallel (as shown), in series, or in combination thereof. When implemented in series, the drop response 604, the slope response 606, and the proportional response 608 can be implemented in various orders.
[0105] Decline response 604 is configured to manage a rapid initial increase in heart rate based on an initial drop in blood temperature when the patient is in an exercise-initiated state (e.g., begins exercising). When an initial drop (i.e., drop) in blood temperature indicating an exercise-initiated state is detected, decline response 604 generates a decline response signal 605 indicating that the heart rate should increase.
[0106] The slope response 606 is configured to manage the rate of increase of the target heart rate relative to the rate at which the blood temperature is increasing. When an increase in blood temperature is detected, the slope response 606 analyzes the rate of change of the blood temperature over a selected time period. When in the initial stage of the exercise state, the slope response 606 generates a slope response signal 607 indicating the rate of change of the target heart rate, which indicates the rate of increase of the blood temperature.
[0107] Proportional response 608 is configured to manage heart rate increases during sustained exercise. To do this, according to certain embodiments, proportional response 608 does not contribute to the rate response during the initial drop in core body temperature at the onset of activity, but thereafter contributes to the rate response during increases in core body temperature in a manner proportional to the difference between the relative temperature signal and the moving baseline temperature signal. According to certain embodiments, during the rise of the blood temperature signal after the initial drop in the blood temperature signal that occurs during the onset of activity, the proportional response provides an increase in the pacing rate based on the difference between the relative temperature signal and the moving baseline temperature signal. In addition, during the drop in the blood temperature signal that occurs in response to a reduction or cessation of activity, the proportional response provides a decrease in the pacing rate based on the difference between the relative temperature signal and the moving baseline temperature signal.
[0108] The three signals 605, 607 and 609 are provided as inputs to a combiner 611 which combines the signals 605, 607 and 609 in a predetermined manner to form a combined response 612 which indicates an overall heart rate increase and / or a target heart rate based on whether the patient is in a motion initiation state, an initial stage of motion, a sustained motion state or a non-motion state. A basal heart rate 610 is also an input to the combiner 611 so that when an increased rate is not required, the combined response signal 612 can be set to the basal heart rate 610. An exemplary basal rate is 60 bpm, but higher or lower basal rates are possible depending on the patient's condition.
[0109] Combined response signal 612 is provided as an input to value limiter block 613, whose function is to limit the range of values of the target heart rate to ensure patient safety. The output of value limiter 614 serves as an input to rate of change limiter 615. The function of rate of change limiter 615 is to limit the rate of change of the target heart rate, thereby preventing sudden changes in heart rate. The output of rate of change limiter 615 is sensor indicated rate 616, which is used by the pacemaker to set the target pacing rate.
[0110] In some embodiments, the processing blocks are rearranged to implement embodiments that operate in an equivalent or similar manner. Figure 6 , base rate 610 is shown entering combiner 611. Since the base rate is a static value, it is possible to combine the base rate 610 with the output of the varying rate limiter 615 and vary the range of the value limiter 613 to achieve an equivalent result.
[0111] Figure 6Each block shown in may have alternative embodiments. Each embodiment may have different characteristics, which allows trade-offs to be made between performance, complexity, code size, etc. It should be appreciated that various combinations of blocks will result in alternative embodiments of the entire algorithm. The following paragraphs describe some alternative embodiments of different processing blocks, including preferred embodiments.
[0112] The PBR block 602 is configured to perform preprocessing to reduce any noise in the raw temperature signal. The PBR block 602 also increases the effective resolution of the temperature measurement. Figure 3 In certain embodiments, preprocessing may be performed by LPF 302. Alternative embodiments may use different time constants, higher order filters, finite impulse response (FIR) filters, nonlinear filtering (e.g., median filters). The function of baseline removal is to produce a relative temperature signal 603 that represents a displacement from a slowly varying baseline. In certain embodiments, the baseline is estimated by LPF 303 and baseline removal is performed by subtraction operation 304. Alternative implementations may use different time constants in the low pass filter, FIR filter, or higher order filter. Alternative embodiments may use different time constants of low pass filters, FIR filters, or higher order filters. In some cases, the baseline may not change significantly during exercise, and therefore the relative signal may not change significantly. In addition to the low pass filter, certain embodiments may also limit the rate of change of the baseline filter output. In certain alternative embodiments, logic 120, one or more processors, or other circuits within the pacemaker detect when exercise is occurring to maintain the value of the baseline. Alternatively or in addition, the baseline may be adjusted on a daily basis to synchronize with the patient's daily temperature pattern.
[0113] Decline response 604 is configured to manage a rapid initial increase in the pacemaker's target heart rate at the onset of exercise (i.e., when the patient is in an exercise-initiated state). Decline response 604 may be implemented by logic 120, one or more processors, or other circuitry within the pacemaker to analyze relative temperature signal 903 to determine the temperature within the blood. A sudden drop in temperature may occur at the onset of exercise. As an example, decline response 604 may be implemented as Figure 3 341, switch 342, and all or part of integrator 343 in. Another embodiment is to use a term proportional to the drop, followed by a nonlinear predetermined function, such as an inverting limiter, followed by an optional filter, such as a bandpass filter. Various combinations of the above embodiments are also within the scope of the embodiments described herein. Alternative embodiments may replace these elements with alternative elements that perform similarly. Exemplary embodiments of integrator 343 are discussed above.
[0114] Slope response 606 is configured to manage the rate of change of the target heart rate while the blood temperature is increasing, where the rate of change depends on the rate of increase of the blood temperature. Physiologically, the blood temperature rises due to the release of heat during exercise. The rate of change of the blood temperature can indicate the nature of the exercise and therefore the appropriate rate of change of the heart rate. In some embodiments, slope response signal 607 is generated by HPF 321, followed by rectifier 322 and multiplier 323, as shown in FIG. Figure 3 As described above, the HPF 321 may be replaced by a BPF, in which case such a BPF may also be implemented by a combination of an LPF and an HPF. Alternative embodiments may determine the slope based on the sampling points of the relative temperature signal 351 or in other ways.
[0115] Proportional response 608 is configured to provide a rate increase from the temperature rise due to continued motion. In one embodiment, proportional response signal 909 is generated by determining moving baseline temperature signal 352 and subtracting moving baseline temperature signal 352 from relative temperature signal 351. Other variations are possible and within the scope of the embodiments described herein.
[0116] Combiner 611 is configured to combine drop response signal 605, slope response signal 607, proportional response signal 609, and base rate 610 into a single combined response signal 612. In one embodiment, only one of drop response signal 605 and slope response signal 607 is combined with the proportional response and base rate to produce combined response signal 612, or more generally, sensor indication rate signal 616. For example, only the larger of drop response signal 605 and slope response signal 607 may be used, or only a predetermined one of the two may be used.
[0117] The value limiter 613 is configured to limit the combined response 612 to remain within a selected range, thereby limiting the sensor indication rate to a value within the selected range. Figure 3 , the upper limit of the selected range is performed by limiter block 326. A lower limit is not required because the previous calculations are configured to avoid producing values below the base rate.
[0118] The rate limiter 615 is configured to limit the rate of change of the target pacing rate. Figure 3, limiting the rate of change of the target pacing rate may be performed by a slew rate limiter 328, which may be implemented, for example, using a low pass filter, but is not limited thereto. A step change in the input to such a low pass filter results in an output change with a finite, exponentially decreasing slope. In certain embodiments, the time constants for positive and negative changes are the same. In alternative embodiments, different time constants may be applied to each direction. In another alternative embodiment, a slew limiter may be utilized rather than a low pass filter, which would limit the change (difference) in the next output value to not exceed a limit value for the output value. Variations of this embodiment may impose different limits on decreasing and increasing changes. Additionally, the limit value may vary based on the current rate.
[0119] In addition, the order of the blocks recorded in the process disclosed herein is only an example of a suitable method. Therefore, the operations associated with these blocks can be rearranged while still within the scope of the present disclosure. Similarly, the attached method claims present operations in an example order and are not necessarily limited to the specific order presented.
[0120] Discussed above Figure 1A and 1B An exemplary leadless pacemaker is used to describe embodiments of the present technology in which embodiments may be implanted. Embodiments of the present technology may be implemented within other types of implantable medical devices (IMDs), or more generally, within other types of implantable medical systems, such as those described below with reference to Figure 7 , 8 and those systems described in 9, but are not limited thereto.
[0121] Figure 7 An intracardiac medical device (ICMD) 700 formed in accordance with embodiments herein is illustrated. The ICMD 700 has been placed through the superior vena cava, through the right atrium, and into the right ventricle of the heart. Alternatively, the ICMD 700 may be introduced through the inferior vena cava. As another option, the ICMD 700 may be introduced through the intra-atrial septum into the left atrium, through the intra-ventricular septum into the left ventricle, through the aorta into the left ventricle, and so on. The atrial septum separates the two atria, and the tricuspid valve is shown between the right atrium and the right ventricle. Figure 7 Also illustrated is a right atrial appendage 729. The reader will appreciate that Figure 7 The illustrations are simplified and somewhat schematic, but nonetheless Figure 7The other views included herein are sufficient to fully illustrate the placement and operation of certain embodiments. The term "ventricular septum" should be used throughout the text to generally refer to any part of the heart that separates the two ventricles (e.g., RA to LA, RA to RV, RV to LV, LA to LV, RA to LV). ICMD 700 is formed according to an embodiment and can represent a pacemaker, a cardiac resynchronization device, a cardioverter, a defibrillator, etc. that operates in DDD mode. When in DDD mode, ICMD 700 can sense in two chambers, pace in two chambers, and inhibit pacing in either chamber based on intrinsic events sensed in the chamber or in another chamber. ICMD 700 is configured to be completely implanted in a single local chamber of the heart. For example, ICMD 700 can be completely and solely implanted in the right atrium or completely and solely implanted in the right ventricle. Optionally, ICMD 700 can be completely and solely implanted in the left atrium or left ventricle by a more invasive implantation method.
[0122] For convenience, the chamber in which ICMD 700 is implanted shall be referred to hereinafter as the "native" chamber. The term "adjacent" chamber shall refer to any chamber that is separated from the native chamber by tissue (e.g., RV, LV, and LA are adjacent chambers of RA; RA and LV are adjacent chambers of LA; RA and RV are adjacent to each other; RV and LV are adjacent to each other, and LV and LA are adjacent to each other).
[0123] ICMD 700 includes a housing 702 including a base 704 and a top 706. Housing 702 extends along a longitudinal axis 709 between base 704 and top 706. Housing 702 is elongated and tubular and extends along longitudinal axis 709. Base 704 is configured to be fixed to a local chamber. Figure 7 In the example of , base 704 is fixed on the right ventricle. Optionally, ICMD 700 can be located on the wall of the left ventricle, left atrium or right atrium, and base 704 is fixed thereon.
[0124] The base 704 includes an active fixation member 710 disposed thereon and extending outwardly from the base 704 generally in the direction of the longitudinal axis 709. A first electrode 711 (also referred to as an active electrode region) is disposed on the active fixation member 710. In alternative embodiments, the first electrode 711 may be disposed adjacent to but not on the active fixation member. U.S. Patent No. 9,242,102 describes a fixation mechanism that is separate from the pacing electrode and disposed at a distal portion of the housing, which may be used in accordance with certain embodiments. The electrode 711 is disposed in a first position such that when the ICMD 700 is implanted in a native chamber, the first electrode 711 engages native wall tissue at a local activation site within the conductive network of the native chamber (e.g., within ventricular wall tissue at the apex of the right ventricle).
[0125] Intracardiac (IC) device extension 750 has a proximal end 752, a distal end 754, and an extension body 756 extending therebetween. The term "infra-cardiac" is used to indicate that IC device extension 750 "generally" resides within the heart and associated vessels, such as the SVC, IVC, CS, pulmonary artery, etc. The term "device" is used to indicate that IC device extension 750 is an extension of ICMD 700. Proximal end 752 is permanently or removably connected (via a joint connector) to housing 702 and is located in a local chamber. A stabilizing arm may be provided at distal end 752 of extension body 756. A right atrial appendage (RAA) fixation mechanism (generally indicated as 757) is disposed at an intermediate point along the length of extension body 756 and aligned with RAA 729. Optionally, the stabilizing arm may be completely removed and extension body 756 may terminate near RAA 729.
[0126] The temperature sensors and circuits for analyzing temperature described in conjunction with FIGS. 1-6 may be disposed in the housing 702 and / or in the IC device extension 750 .
[0127] exist Figure 7 In the example of the embodiment of the present invention, the extension body 756 includes a chamber transition subsegment 758, an active transition segment 760, and a stabilizer end segment 762. The stabilizer end segment 762 is an exemplary structural embodiment of a stabilizer arm. The RAA fixation mechanism 757 is an exemplary structural embodiment of the active transition segment 760. The chamber transition subsegment 758 is long enough to extend from a local chamber (e.g., the right ventricle) through the tricuspid valve to an adjacent chamber (e.g., the right atrium). The chamber transition subsegment 758 extends upwardly out of the right ventricle, and its direction is generally along the longitudinal axis 709.
[0128] Extension body 756 is formed of a biocompatible insulating material, such as EFTE, silicon, OPTIM, etc. In general, extension body 756 is formed of a material that is flexible but exhibits a desired degree of shape memory so that once it is implanted, active transition segment 760 and stabilizer end segment 762 will tend to return to a pre-formed shape. One or more insulated wires are secured within extension body 756 and span from ICMD 700 to any sensors or electrodes disposed on extension body 756.
[0129] The stabilizer end segment 762 is located at the distal end 754 and has a preformed shape that is biased to extend slightly outward in a transverse direction (generally indicated as 764) relative to the length of the chamber in which the stabilizer end segment 762 is located. The stabilizer end segment 762 engages with a first area of the heart. For example, the stabilizer end segment 762 can extend upward to the SVC and engage therewith. Alternatively, the stabilizer end segment 762 can extend downward to the IVC and engage therewith. Alternatively, the stabilizer end segment 762 can extend to the coronary sinus, the pulmonary artery, etc.
[0130] The stabilizer end segment 762 is pre-formed into a predetermined shape based on which portion of the cavity is to be engaged. The flexible stabilizer end segment 762 can be wound into at least one circle having a pre-formed diameter. For example, when it is intended to safely engage the SVC, the stabilizer end segment 762 can be formed into a spiral with one or more windings or coils that are pre-arranged or biased to radially expand to a diameter sufficient to securely fit the inner wall of the SVC.
[0131] Optionally, the stabilizer end segment 762 can utilize alternative shapes for SVC stability, such as S-shaped, T-shaped, Y-shaped, U-shaped, etc. Optionally, the stabilizer end segment 762 can be divided into multiple (e.g., 2-4) stabilizer end segments that extend outward in different directions and contact different areas of wall tissue. The conductor wire extends from the ICMD to the second electrode within the extension body 756, and the conductor terminates at the second electrode, so that the stabilizer end segment 762 does not have an electrode and a conductor wire. When the stabilizer end segment 762 lacks any sensor or electrode, the stabilizer end segment 762 will also lack any internal wire.
[0132] Optionally, stabilizer end segment 762 may include one or more conductors to be coupled to a programmer during implantation that span from distal end 754 to ICMD 700 to provide communications, power, remote access to electrodes, and the like.
[0133] The active transition segment 760 includes one or more electrodes 768 disposed thereon and within a C-shaped or U-shaped groove region 774. The electrodes 768 are spaced apart from one another within the groove region 774 by inter-electrode spacing 770. For example, the second electrode 768 can be biased toward engaging wall tissue in the right atrial appendage 729. The second electrode 768 engages distal wall tissue at a distal activation site within conductive tissue of an adjacent chamber (relative to the chamber in which the ICMD 700 is implanted). Optionally, teeth or other active fixation features can be included around the hump or groove portion of the active transition segment 760 to enhance fixation as a RAA fixation mechanism.
[0134] As described below, a controller is provided within the housing 702 to enable stimulation pulses to be delivered to the local and remote activation sites, respectively, via the first electrode 711 and the second electrode 768, in a dual-chamber synchronized manner. The stimulation pulses delivered at the remote activation site are timed so as to cause contraction of an adjacent chamber in a predetermined relationship to contraction of the local chamber. For example, the ICMD 700 may be configured to control delivery of stimulation pulses from the first electrode 711 and the second electrode 768 to the right atrium and the right ventricle according to a DDD pacing mode, while the ICMD is entirely located in one of the right atrium and the right ventricle. For example, the controller may be configured to control delivery of stimulation pulses from the first electrode 711 and the second electrode 768 to the left atrium and the left ventricle according to a DDD pacing mode, while the ICMD is entirely located in one of the left atrium and the left ventricle.
[0135] Figure 8 A cardiac pacemaker and / or implantable cardioverter defibrillator (ICD) is described that utilizes one or more conductive leads that pass through blood vessels and cardiac chambers to connect a can with electronics and a power source (can) to electrodes attached to the heart for purposes of electrically stimulating cardiac tissue and measuring myocardial electrical activity. In certain alternative embodiments, a subcutaneous ICD does not utilize endocardial, transvenous, or epicardial leads, and defibrillation may be delivered using subcutaneous electrodes formed in accordance with embodiments herein. For a more detailed description of a subcutaneous ICD, the reader is referred to U.S. Patent No. 7,925,343, "Subcutaneous implantable cardiac device system with low defibrillation thresholds and improved sensing" (Min), which is incorporated herein by reference.
[0136] exist Figure 8 In the present invention, temperature sensing can be performed in conjunction with an implantable cardiac device (e.g., a stimulation device, such as an implantable cardioverter-defibrillator, a pacemaker, etc.). Here, one or more of the operations described above can be implemented in or combined with such an implantable cardiac device. It should be understood that this example is provided for illustrative purposes and that temperature sensing can be implemented using other types of devices.
[0137] Figure 8 An implantable cardiac device 800 is illustrated in electrical communication with a patient's heart H by means of three leads 804, 806, and 808, adapted to deliver multi-chamber stimulation and shock therapy. To sense atrial cardiac signals and provide right atrial chamber stimulation therapy, the device 800 is coupled to an implantable right atrial lead 804 having, for example, an atrial tip electrode 820, which is typically implanted in the patient's right atrial appendage or atrial septum. Figure 8Also shown is the right atrial lead 804 having an optional atrial ring electrode 821 .
[0138] To sense left atrial and ventricular cardiac signals and provide left chamber pacing therapy, the device 800 is coupled to a coronary sinus lead 806 designed to be placed in the coronary sinus region via the coronary sinus for positioning a distal electrode adjacent to the left ventricle and / or an additional electrode(s) adjacent to the left atrium. As used herein, the phrase "coronary sinus region" refers to the vasculature of the left ventricle, including any portion of the coronary sinus, the great cardiac vein, the left marginal vein, the left posterior ventricular vein, the middle cardiac vein, and / or the venules or any other cardiac vein accessible by the coronary sinus.
[0139] Thus, the exemplary coronary sinus lead 806 is designed to receive atrial and ventricular signals and deliver left ventricular pacing therapy using, for example, the left ventricular tip electrode 822 and the optional left ventricular ring electrode 823; provide left atrial pacing therapy using, for example, the left atrial ring electrode 824; and provide shock therapy using, for example, the left atrial coil electrode 826 (or other electrodes capable of delivering shocks). For a more detailed description of the coronary sinus lead, the reader is referred to U.S. Patent No. 5,466,254, "Coronary Sinus Lead with Atrial Sensing Capability".
[0140] The device 800 is also shown in electrical communication with the patient's heart H by way of an implantable right ventricular lead 808, which in this embodiment has a right ventricular tip electrode 828, a right ventricular ring electrode 830, a right ventricular (RV) coil electrode 832 (or other electrode capable of delivering a shock), and a superior vena cava (SVC) coil electrode 834 (or other electrode capable of delivering a shock). Typically, the right ventricular lead 808 is inserted transvenously into the heart H so that the right ventricular tip electrode 828 is placed at the apex of the right ventricle, so that the RV coil electrode 832 will be positioned in the right ventricle, and the SVC coil electrode 834 will be positioned in the superior vena cava. Thus, the right ventricular lead 808 is capable of sensing or receiving cardiac signals and delivering stimulation to the right ventricle in the form of pacing and shock therapy.
[0141] Any of the leads 804, 806, and 808 can include one or more temperature sensors, as taught herein. Temperature signals generated by the temperature sensors can be transmitted to the device 800 via one or more conductors running through the corresponding cardiac leads. The device 800 can then use the corresponding temperature readings to initiate or change therapy for the patient, or forward the temperature information or sensor-indicated rate response or other programming information to an external device, such as a leadless pacemaker or a programmer external to the patient.
[0142] In certain embodiments, conductors associated with other components of lead body 808 (eg, electrodes 828, 830, and 832) may be routed through channel(s) in the bottom of the sensor assembly.
[0143] It should be understood that temperature may be measured in various chambers of the heart or associated blood vessels, and that other mechanisms may be employed to measure temperature in a particular chamber or vessel.
[0144] Device 800 can be connected to other leads than those specifically shown. In addition, the leads connected to device 800 can include components other than those specifically shown. For example, the leads can include other types of electrodes, sensors, or devices used to interact with the patient or the surrounding environment in other ways.
[0145] In some embodiments, code including instructions (e.g., software, firmware, middleware, etc.) may be executed on one or more processing devices to implement one or more of the described functions or components. The code and related components (e.g., data structures and other components that are passed through the code or execute the code) may be stored in an appropriate data storage that can be read by the processing device (e.g., commonly referred to as a computer-readable medium).
[0146] The components and functions described herein can be connected or coupled in many different ways. The manner of doing so may depend in part on whether and how the component is separated from other components. In some embodiments, some connections or couplings represented by the lead-out lines in the figure can be implemented in an integrated circuit, as discrete wires, or otherwise implemented.
[0147] In addition, the order of the blocks recorded in the process disclosed herein is only an example of a suitable method. Therefore, the operations associated with these blocks can be rearranged while still within the scope of the present disclosure. Similarly, the attached method claims present operations in an example order and are not necessarily limited to the specific order presented.
[0148] refer to Fig. 9, a schematic diagram shows an embodiment of a cardiac pacing system 900 comprising one or more leadless cardiac pacemakers 902 with conducted communication for performing cardiac pacing in conjunction with an implantable cardioverter-defibrillator (ICD) 906. The system 900 can implement, for example, single-chamber pacing, dual-chamber pacing, or triple-chamber pacing for cardiac resynchronization therapy without requiring pacing leads connected to the defibrillator 906. The illustrative cardiac pacing system 900 includes at least one leadless cardiac pacemaker 902 configured to be implanted in electrical contact with a cardiac chamber 904 and configured to perform cardiac pacing functions in combination with a co-implanted implantable cardioverter-defibrillator (ICD) 906. The one or more leadless cardiac pacemakers 902 can include at least two leadless electrodes 908 configured to deliver cardiac pacing pulses, sense induced and / or natural cardiac electrical signals, and communicate unidirectionally or bidirectionally with the co-implanted ICD 906.
[0149] According to certain embodiments, a temperature sensor can be disposed in or integrally attached to the housing of one or more leadless pacemakers 902, and circuitry to analyze a temperature signal generated by the temperature sensor can be disposed in the housing of an ICD 906, which can be a subcutaneous ICD. According to certain embodiments, the circuitry to analyze temperature can be disposed in the housing of one of the leadless pacemakers 902, and the temperature sensor can be located in the other leadless pacemaker 902. Other variations in the placement of the temperature sensor and the circuitry to analyze temperature will be appreciated by those skilled in the art in view of the disclosure herein.
[0150] In addition, it should be understood that any reference to elements using names such as "first", "second" and the like herein generally does not limit the quantity or order of these elements. On the contrary, these names can be used as a convenient method to distinguish two or more different elements or element instances in this article. Therefore, the reference to the first and second elements does not mean that only two elements can be used, or means that the first element must precede the second element in some way. In addition, unless otherwise specified, a group of elements may include one or more elements. In addition, the term "at least one of A, B or C" or "one or more of A, B or C" or "at least one of the group consisting of A, B and C" used in the specification or claims means "A or B or C or any combination of these elements". For example, this term can include A, or B, or C, or A and B, or A and C, or A and B and C, or 2A, or 2B, or 2C, etc.
[0151] As used herein, the term "determine" encompasses a variety of actions. For example, "determine" may include calculating, computing, processing, deriving, investigating, searching (e.g., searching in a table, a database, or another data structure), ascertaining, etc. Additionally, "determine" may include receiving (e.g., receiving information), accessing (e.g., accessing data in a memory), etc. Additionally, "determine" may include resolving, selecting, choosing, establishing, etc.
[0152] Although certain embodiments have been described in detail above and shown in the accompanying drawings, it should be understood that these embodiments are illustrative only and are not intended to limit the teachings herein. In particular, it should be appreciated that the teachings herein are applicable to a wide variety of devices and methods. Therefore, it should be appreciated that various modifications may be made to the illustrated embodiments or other embodiments without departing from their broad scope. In view of the foregoing, it will be appreciated that the teachings herein are intended to cover any changes, adjustments, or modifications within the scope of the present disclosure.
[0153] The blocks, modules and controllers described herein can be implemented in various ways, such as by one or more of dedicated hardware, circuits (integrated or discrete), firmware and / or microprocessor-based architectures. One or more of the blocks, modules and controllers described herein can include any processor-based or microprocessor-based systems, including systems using microcontrollers, reduced instruction set computers (RISC), application-specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), logic circuits, and any other circuits or processors capable of performing the functions described herein. In addition or alternatively, (module / controller) represents a circuit module of hardware associated with instructions for performing the operations described herein (e.g., software stored on tangible and non-temporary computer-readable storage media such as computer hard disks, ROMs, RAMs, etc.). The above examples are merely exemplary and are therefore not intended to limit the definition and / or meaning of the term "controller" in any way. Blocks, modules and controllers and can execute instruction sets stored in one or more storage elements to process data. Storage elements can also store data or other information as desired or required. Storage elements can be in the form of information sources or physical memory elements within blocks, modules and controllers. The instruction set may include various commands that instruct the (block / controller) to perform specific operations, such as the methods and processes of various embodiments of the subject matter described herein. The instruction set may be in the form of a software program. The software may be in various forms such as system software or application software. In addition, the software may be in the form of a collection of independent programs or modules, program modules within a larger program, or parts of program modules. The software may also include modular programming in the form of object-oriented programming. The processing of input data by the processor may be in response to user commands, or in response to the results of previous processing, or in response to a request made by another processor.
[0154] It should be understood that the subject matter described herein is not limited to the structural details and component arrangements set forth in the description herein or shown in the drawings herein in its application. The subject matter described herein can have other embodiments and can be practiced or executed in various ways. In addition, it should be understood that the phrases and terms used herein are for descriptive purposes and should not be considered restrictive. The use of "including", "comprising" or "having" and its variants herein is intended to include the items listed thereafter and their equivalents and additional items.
[0155] Unless otherwise defined, all technical terms used herein have the same meanings as those generally understood by ordinary technicians in the field of cardiac technology. Specific methods, devices and materials may be described in this application, but any methods and materials similar or equivalent to the methods and materials described herein can be used in the practice of this technology. Although some detailed descriptions of the embodiments of the present technology have been made and illustrated in an exemplary manner, such descriptions are only for the purpose of clear understanding and are not intended to be limiting. Various terms have been used in the description to convey an understanding of the present technology; it should be understood that the meanings of these various terms extend to common language or grammatical changes or forms thereof. It should also be understood that when a term refers to a device, equipment or drug that has been referenced by a trade name, brand name or generic name, these terms or names are provided as contemporary examples, and the present technology is not limited by such literal scope. Terms that can be reasonably understood as derivatives of contemporary terms or specifying a hierarchical subset contained in contemporary terms introduced later will be understood to have been described by current contemporary terms. In addition, although some theoretical considerations have been proposed to promote the understanding of the present technology, the claims to the present technology are not subject to such theories. In addition, any one or more features of any embodiment of the present technology may be combined with any one or more other features of any other embodiment of the present technology without departing from the scope of the present technology. In addition, it should be understood that the present technology is not limited to the embodiments that have been described for the purpose of illustration, but can only be defined by a fair interpretation of the claims attached to the patent application, including the full range of equivalents to which each element therein is entitled.
[0156] It should be understood from the above that the various structures and functions described herein can be incorporated into various devices (e.g., leads, monitoring devices, stimulation devices, etc.) and implemented in various ways. Different embodiments of biostimulators can include various hardware and software processing components. In some embodiments, hardware components (such as processors, controllers, state machines, logic, or some combination of these components) can be used to implement the components or circuits.
[0157] In some embodiments, code including instructions (e.g., software, firmware, middleware, etc.) may be executed on one or more processing devices to implement one or more of the described functions or components. The code and related components (e.g., data structures and other components that are executed by the code or by the code) may be stored in an appropriate data storage that can be read by the processing device (e.g., which is generally referred to as a computer-readable medium).
[0158] In addition, some operations described herein can be performed by devices located externally relative to the patient's body. For example, an implanted device can simply send raw or processed data to an external device, which then performs the necessary processing.
[0159] The components and functions described herein can be connected or coupled in many different ways. The manner of doing so may depend in part on whether and how the component is separated from other components. In some embodiments, some connections or couplings represented by the lead-out lines in the figure can be implemented in an integrated circuit, as discrete wires, or otherwise implemented.
[0160] The order of the blocks recorded in the process disclosed herein is merely an example of a suitable method. Therefore, the operations associated with these blocks can be rearranged while still within the scope of the present disclosure. Similarly, the attached method claims present operations in an example order and are not necessarily limited to the specific order presented.
Claims
1. A method for use with an implantable medical system, comprising: generating a relative temperature signal based on a blood temperature signal indicative of a core body temperature of a patient in which the implantable medical system is implanted; generating a moving baseline temperature signal based on the relative temperature signal such that the moving baseline temperature signal follows the relative temperature signal during an initial drop in the blood temperature signal that occurs during the initiation of activity and the moving baseline temperature signal decays toward zero during a rise in the blood temperature signal that follows the initial drop in the blood temperature signal; generating a proportional response signal based on the relative temperature signal and the moving baseline temperature signal; as well as A sensor indicated rate response signal is generated based on the proportional response signal and the base rate.
2. The method of claim 1, wherein: Generating the proportional response signal based on the relative temperature signal and the moving baseline temperature signal comprises: subtracting the moving baseline temperature signal from the relative temperature signal to produce a difference signal indicative of a difference between the relative temperature signal and the moving baseline temperature signal; and The proportional response signal is generated based on a positive portion of the difference signal.
3. The method of claim 2, wherein: Generating the proportional response signal based on the positive portion of the difference signal comprises: multiplying the positive portion of the difference signal by a proportional gain value to generate the proportional response signal; or A predetermined function is applied to the positive portion of the difference signal to generate the proportional response signal.
4. The method of claim 1, wherein: the proportional response signal providing an increase in pacing rate based on a difference between the relative temperature signal and the moving baseline temperature signal during a rise in the blood temperature signal following an initial drop in the blood temperature signal occurring during the onset of activity; as well as During a drop in the blood temperature signal that occurs in response to a reduction or cessation of activity, the proportional response provides a reduction in the pacing rate based on a difference between the relative temperature signal and the moving baseline temperature signal.
5. The method of claim 1, further comprising: generating at least one of a drop response signal or a slope response signal; and wherein the sensor indication rate response signal is also generated based on at least one of the drop response signal or the slope response signal; wherein the falling response signal provides an increase in pacing rate during an initial drop in the blood temperature signal that occurs during the initiation of activity; and Wherein, during a rise in the blood temperature signal following an initial drop in the blood temperature signal, the slope response signal provides an increase in the pacing rate based on the slope of the relative temperature signal.
6. The method of claim 5, wherein: Generating at least one of the falling response signal or the slope response signal comprises generating both the falling response signal and the slope response signal; and Generating the sensor-indicative rate response signal includes generating a rate adjustment signal based on a combination of the proportional response signal, the falling response signal, the slope response signal, and the base rate.
7. The method of claim 6, wherein: Generating the sensor indicated rate response signal based on a combination of the proportional response signal, the falling response signal, the slope response signal and the base rate includes generating the sensor indicated rate response signal by accumulating the proportional response signal, the falling response signal, the slope response signal and the base rate.
8. The method of claim 6, wherein: Generating the falling response signal comprises: comparing the relative temperature signal to a falling threshold; When the relative temperature signal is less than a decreasing threshold, providing a decreasing starting rate value to an input of an integrator; providing a falling decay rate value to an input of the integrator when the relative temperature signal is greater than the falling threshold; and A positive portion of the signal output by the integrator is used as the falling response signal.
9. The method of claim 6, wherein: Generating the slope response signal comprises: generating a signal indicative of a positive slope of the relative temperature signal; and The slope response signal is generated by multiplying a signal indicative of a positive slope of the relative temperature signal by a slope gain value, or by applying a predetermined function to a signal indicative of a positive slope of the relative temperature signal.
10. The method of claim 9, wherein: Generating a signal indicative of a positive slope of the relative temperature signal comprises: providing the relative temperature signal to a high pass filter HPF to generate a signal indicating the slope of the relative temperature signal, and providing the output of the HPF to a rectifier to generate a signal indicating the positive slope of the relative temperature signal; or A difference between two temporally different samples of the relative temperature signal is determined, and a signal indicative of a positive slope of the relative temperature signal is generated based on the difference.
11. The method of claim 1, wherein: Generating the relative temperature signal based on the blood temperature signal comprises: generating a short-term average STA of the blood temperature signal; generating a long-term average LTA of the blood temperature signal; and The relative temperature signal is generated by subtracting the LTA of the blood temperature signal from the STA of the blood temperature signal.
12. The method of claim 1, wherein: Generating the sensor indicating a rate response signal comprises: generating a rate adjustment signal based on the proportional response signal; adding the rate adjustment signal to a base rate to generate the sensor indicated rate response signal; and At least one of an amplitude or a slew rate of the sensor indication rate response signal is limited.
13. An implantable medical system comprising: one or more pulse generators configured to selectively generate pacing pulses; one or more electrodes configured to deliver pacing pulses generated by at least one of the one or more pulse generators to a heart of a patient in which the implantable medical system is implanted; a temperature sensor configured to generate a blood temperature signal indicative of a core body temperature of a patient in which the implantable medical system is implanted; as well as The controller is configured as: generating a relative temperature signal based on the blood temperature signal; generating a moving baseline temperature signal based on the relative temperature signal, wherein the moving baseline temperature signal follows the relative temperature signal during an initial drop in the blood temperature signal that occurs during the initiation of activity, and wherein the moving baseline temperature signal decays toward zero during a rise in the blood temperature signal that follows the initial drop in the blood temperature signal; generating a proportional response signal based on the relative temperature signal and the moving baseline temperature signal; generating a sensor indicated rate response signal based on the proportional response signal and the base rate; and Delivery of the pacing pulses is controlled based on the sensor-indicative rate response signal, thereby controlling the pacing rate.
14. The implantable medical system of claim 13, wherein: The controller is configured to generate the proportional response signal based on the relative temperature signal and the moving baseline temperature signal by: subtracting the moving baseline temperature signal from the relative temperature signal to produce a difference signal indicative of a difference between the relative temperature signal and the moving baseline temperature signal; as well as The proportional response signal is generated based on a positive portion of the difference signal.
15. The implantable medical system of claim 13, wherein: the proportional response signal providing an increase in the pacing rate based on a difference between the relative temperature signal and the moving baseline temperature signal during a rise in the blood temperature signal following an initial drop in the blood temperature signal occurring during the onset of activity; as well as During a drop in the blood temperature signal that occurs in response to a reduction or cessation of activity, the proportional response provides a reduction in the pacing rate based on a difference between the relative temperature signal and the moving baseline temperature signal.
16. The implantable medical system of claim 13, wherein: The controller is also configured to: generating at least one of a drop response signal or a slope response signal; and further generating the sensor indicated rate response signal based on at least one of the drop response signal or the slope response signal; wherein the falling response signal provides an increase in the pacing rate during an initial drop in the blood temperature signal occurring during the initiation of activity; and Wherein, during a rise in the blood temperature signal following an initial drop in the blood temperature signal, the slope response signal provides an increase in the pacing rate based on the slope of the relative temperature signal.
17. The implantable medical system of claim 16, wherein: The controller is also configured to: generating both the falling response signal and the slope response signal; and A sensor indicated rate response signal is generated based on a combination of the proportional response signal, the falling response signal, the slope response signal, and the base rate.
18. The implantable medical system of claim 17, wherein: The controller is configured to: comparing the relative temperature signal to a falling threshold; When the relative temperature signal is less than a decreasing threshold, providing a decreasing starting rate value to an input of an integrator; providing a decreasing decay rate value to an input of the integrator when the relative temperature signal is greater than the decreasing threshold; as well as A positive portion of the signal output by the integrator is used as the falling response signal.
19. The implantable medical system of claim 17, wherein the controller is configured to add the proportional response signal, the falling response signal, the slope response signal, and the basic rate to generate the sensor indication rate response signal, and to limit at least one of an amplitude or a slew rate of the sensor indication rate response signal.
20. The implantable medical system of claim 13, wherein the controller is configured to: generating a short-term average STA of the blood temperature signal; generating a long-term average LTA of the blood temperature signal; and The relative temperature signal is generated by subtracting the LTA of the blood temperature signal from the STA of the blood temperature signal.
